# Risk of Ophthalmic Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/risk-of-ophthalmic-adverse-events-in-patients-treated-with-immune-checkpoint/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yanli Hou,Di-ya Wang,Jiexuan Hu,Ruyue Tian,Wei Wang,Qiang Su,Hongyang Li,Yanling Wang |
| Citations | 11 |
| DOI | 10.1080/09273948.2021.1890133 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3197973943 |
| PMID | 33970759 |
| Type | review |
| Year | 2021 |

## Paper authors

- [Di-ya Wang](https://scholariq.org/researchers/di-ya-wang/)

## Paper journal

- [Ocular Immunology and Inflammation](https://scholariq.org/journals/ocular-immunology-and-inflammation/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.